Virtus LifeSci Performance

BBC -- USA Etf  

USD 33.55  0.20  0.59%

The entity has beta of 0.8546 which indicates Virtus LifeSci returns are very sensitive to returns on the market. as market goes up or down, Virtus LifeSci is expected to follow.. Even though it is essential to pay attention to Virtus LifeSci Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-eight different technical indicators which can help you to evaluate its performance.
 Time Horizon     30 Days    Login   to change

Virtus LifeSci Biotech Relative Risk vs. Return Landscape

If you would invest  3,492  in Virtus LifeSci Biotech Clinical Trls ETF on June 19, 2018 and sell it today you would lose (116.50)  from holding Virtus LifeSci Biotech Clinical Trls ETF or give up 3.34% of portfolio value over 30 days. Virtus LifeSci Biotech Clinical Trls ETF is generating negative expected returns assuming volatility of 1.505% on return distribution over 30 days investment horizon. In other words, 13% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, Virtus LifeSci Biotech Clinical Trls ETF is expected to under-perform the market. In addition to that, the company is 2.56 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.12 per unit of volatility.

Virtus LifeSci Market Risk Analysis

Sharpe Ratio = -0.0952
Good Returns
Average Returns
Small Returns
Negative ReturnsBBC

Virtus LifeSci Relative Performance Indicators

Estimated Market Risk
  actual daily
 87 %
of total potential
Expected Return
  actual daily
 1 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average Virtus LifeSci is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.

Performance Rating

Virtus LifeSci Biotech Clinical Trls ETF Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Over the last 30 days Virtus LifeSci Biotech Clinical Trls ETF has generated negative risk-adjusted returns adding no value to investors with long positions.

Virtus LifeSci Alerts

Equity Alerts and Improvement Suggestions
Virtus LifeSci generates negative expected return over the last 30 days
The fund generated three year return of -1.0%
Virtus LifeSci Biotech Clinical Trls ETF holds 99.71% of its assets under management (AUM) in equities

Virtus LifeSci Biotech Dividends Analysis

Check Virtus LifeSci Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.